Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows an updated “Revision” identifier for the ClinicalTrials.gov interface (v3.5.3 instead of v3.5.2), reflecting a software/content template update rather than a change to the clinical study details.
    Difference
    0.1%
    Check dated 2026-04-27T07:33:36.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-20T02:16:52.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    - Revision: v3.5.0 is now shown, replacing the previous Revision: v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-22T04:36:16.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Page revision updated to v3.4.3. The previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-06T18:00:32.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page revision updated from v3.4.1 to v3.4.2, which seems to be a minor metadata update with no substantive changes to study design, criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:33:47.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page lists an administrative revision update from v3.4.0 to v3.4.1; no changes to study details, eligibility criteria, or user interactions are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T14:17:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.